Yves Humblet

1 ta ish

UCLouvain Saint-Louis Brussels

1. Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial

   Axel Grothey, Eric Van Cutsem, Alberto Sobrero +17

   Maqola20123 iqtibos

   ABIABI:AkademIndex/2026.other.241897